Pharmaceutical Companies Buy Rival’s Drugs, Then Jack Up the Prices

April 27, 2015 1:52 AM

82 23

Pharmaceutical Companies Buy Rival’s Drugs, Then Jack Up the Prices

List prices soar on Valeant’s heart medications and other firm’s drugs, driving up costs

On Feb. 10, Valeant Pharmaceuticals International Inc. VRX 0.49 % bought the rights to a pair of life-saving heart drugs. The same day, their list prices rose by 525% and 212%.

Read more

To category page

Loading...